The purpose of this study is to see if the investigator can help the immune system to work
against myeloma. Because cancer is produced by the patients own body, the immune system does
not easily recognize and fight cancer cells. The immune system needs to be "trained" to do
This disease has been selected for this study because the Wilms Tumor 1 (WT1) protein is
often present in myeloma cells. WT1 is a gene that is involved in the normal development of
kidneys and other organs. When the WT1 gene becomes abnormal, it can make proteins involved
in the development of cancer. This study will determine whether the WT1 vaccine causes an
immune response which is safe and able to keep the myeloma from coming back.